XML 47 R26.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Components of selected captions in the consolidated condensed balance sheets consisted of the following:
June 30, 2023December 31, 2022
Inventories
Raw materials$181.2 $156.4 
Work in process223.0 177.4 
Finished products576.0 541.7 
$980.2 $875.5 
Schedule of Accrued and Other Liabilities
June 30, 2023December 31, 2022
Accrued and other liabilities 
Employee compensation and withholdings$312.7 $268.7 
Taxes payable106.6 50.6 
Property, payroll, and other taxes56.1 45.6 
Research and development accruals70.7 66.9 
Accrued rebates130.1 116.1 
Fair value of derivatives17.8 20.7 
Accrued marketing expenses16.9 17.0 
Legal and insurance30.4 28.1 
Litigation settlement (a)
69.2 53.3 
Accrued relocation costs23.3 25.2 
Accrued professional services10.2 6.6 
Accrued realignment reserves14.4 15.6 
Other accrued liabilities81.5 80.6 
$939.9 $795.0 
_______________________________________
(a)     As of June 30, 2023, $69.2 million was accrued in "Accrued and Other Liabilities" and $112.5 million was accrued in "Litigation Settlement Accrual" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.
Schedule of Supplemental Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Six Months Ended
June 30,
20232022
Cash paid during the year for:
Income taxes$193.5 $173.0 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$14.3 $14.5 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$6.0 $10.6 
Capital expenditures accruals$26.9 $24.6 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6